Key result
Ivabradine and metoprolol tartrate were compared for their impact on heart rate variability in patients with angina pectoris.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Ivabradine-metoprolol comparison on HRV in angina should not change practice yet; leaves open need for randomized trials.
Introduction Heart rate variability (HRV) is accessible, informative and efficient way to estimate the balance of sympathetic and parasympathetic nervous system of the heart [1]. Some HRV parameters correlate with the frequency of unfavorable cardiovascular events [2,3] and are used to assess the patients’ state, to predict outcomes and to optimize
No takes yet. Share an insight, caveat, or question.
Загидуллин et al. (2014) studied this question. Ivabradine and metoprolol tartrate were compared for their impact on heart rate variability in patients with angina pectoris.
Synapse has enriched 10 related papers. Consider them for comparative context: